Packaging and Distribution

Back in person at the Javits Center, exhibitors present containers, components, equipment, and services to fill, ship, protect, and optimize the packaging process.

The organizers of Pharmapack Europe have released the results of its global drug delivery and packaging survey, demonstrating the continuation of the United States’ lead in innovation.

Low- and middle-income countries are at the greatest risk of receiving substandard and falsified COVID-19 vaccines.

Stakeholders work to meet deadlines, maximize benefits, and close gaps.

FDA will now require new and updated warnings about the increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions.

Consider tactics to meet sustainability objectives for temperature-controlled packaging.

Datwyler offers the StarterPack packaging system designed to aid in the development of parenteral drug packaging.

Developers might invest in small-scale equipment to produce packaging for stability studies in-house, or they might outsource production. Manufacturers should consider the benefits and risks to both approaches.

Aenova has announced plans to open a new new can and bottle filling production line in Cornu, Romania.

Manufacturers seek more sustainable options for temperature-controlled packaging.

Container and equipment innovations expand applications.

Amgen’s greenfield facility near Columbus, Ohio to assemble and package vials and syringes is expected to be operational by 2024.

Pharmapack Europe event organizers have revealed increased levels of innovation in drug delivery across the industry, substantiated by the level of regulatory approvals.

The added capabilities include clinical-scale sachet and blister packaging for clinical trial pharmaceuticals and a relationship with a European Union Qualified Person for its CTS offerings.

Contract packaging organizations packaging biologic drugs for clinical trials use technologies that meet the unique requirements of each study.

Supply-chain visibility systems are proving their worth in the distribution of COVID-19 vaccines and may see broader use in the future.

Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines.

Complex formulations, personalized medicines, COVID-19 therapies, and sustainability goals are driving innovations in drug packaging.

CalAmp's new sensor for cold-chain applications provides visibility for shipping vaccines.

Material properties play a role in container closure integrity under frozen or cryogenic storage temperatures.

Drug product security requires anti-counterfeiting techniques such as authentication throughout the supply chain.

Dosage-level authentication provides an added digital layer of security for pharmaceutical companies to ensure their products are not exposed to falsification.

The partnership will combine Cold Chain Technologies thermal packaging with B Medical Systems’ stationary refrigeration solutions for temperature-critical pharmaceuticals.

Under an expanded agreement with J&J, Catalent Biologics will increase manufacturing capacity at its Anagni, Italy, site to accommodate the large-scale commercial supply of Janssen’s COVID-19 vaccine.

Smart packaging opens doors to new products for diagnosis and treatment of eye problems.